Lourdes Mateu

2.9k total citations
48 papers, 474 citations indexed

About

Lourdes Mateu is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Lourdes Mateu has authored 48 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 16 papers in Neurology and 13 papers in Epidemiology. Recurrent topics in Lourdes Mateu's work include COVID-19 Clinical Research Studies (15 papers), Long-Term Effects of COVID-19 (14 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Lourdes Mateu is often cited by papers focused on COVID-19 Clinical Research Studies (15 papers), Long-Term Effects of COVID-19 (14 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Lourdes Mateu collaborates with scholars based in Spain, United Kingdom and United States. Lourdes Mateu's co-authors include Antoni Bayés‐Genís, Nieves Sopena, Miquel Sabrià, Núria Vallejo, Albert Teis, Roger Paredes, María Luisa Pedro-Botet, Bonaventura Clotet, Marian García-Núñez and Marta Massanella and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Lourdes Mateu

47 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lourdes Mateu Spain 12 237 133 107 77 52 48 474
Arta Karruli Italy 9 109 0.5× 60 0.5× 68 0.6× 21 0.3× 18 0.3× 18 284
Suyun Qian China 13 156 0.7× 53 0.4× 145 1.4× 36 0.5× 32 0.6× 49 453
Siew‐Wai Fong Singapore 12 300 1.3× 173 1.3× 41 0.4× 33 0.4× 37 0.7× 22 474
Kévin Alexandre France 10 61 0.3× 60 0.5× 67 0.6× 26 0.3× 7 0.1× 23 316
Akshay Khatri United States 10 206 0.9× 44 0.3× 77 0.7× 22 0.3× 28 0.5× 26 354
Alessandro Torre Italy 9 122 0.5× 86 0.6× 100 0.9× 13 0.2× 26 0.5× 25 433
Ananthakrishnan Ramani United States 9 167 0.7× 20 0.2× 200 1.9× 16 0.2× 50 1.0× 18 392
María Ruiz‐Ruigómez Spain 11 127 0.5× 53 0.4× 119 1.1× 6 0.1× 28 0.5× 30 331
Andreas Lind Norway 11 205 0.9× 91 0.7× 70 0.7× 15 0.2× 15 0.3× 32 383
Mario Karolyi Austria 12 245 1.0× 92 0.7× 71 0.7× 8 0.1× 18 0.3× 34 333

Countries citing papers authored by Lourdes Mateu

Since Specialization
Citations

This map shows the geographic impact of Lourdes Mateu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lourdes Mateu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lourdes Mateu more than expected).

Fields of papers citing papers by Lourdes Mateu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lourdes Mateu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lourdes Mateu. The network helps show where Lourdes Mateu may publish in the future.

Co-authorship network of co-authors of Lourdes Mateu

This figure shows the co-authorship network connecting the top 25 collaborators of Lourdes Mateu. A scholar is included among the top collaborators of Lourdes Mateu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lourdes Mateu. Lourdes Mateu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berry, Mark, Amanda M. Kong, Roger Paredes, et al.. (2025). Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19. Scientific Reports. 15(1). 27441–27441. 1 indexed citations
2.
Pradenas, Edwards, Víctor Urrea, Sílvia Marfil, et al.. (2025). Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters. Journal of Translational Medicine. 23(1). 783–783. 2 indexed citations
3.
Franco, Sandra, Lourdes Mateu, Raquel Pluvinet, et al.. (2024). Altered Plasma microRNA Signature in Hospitalized COVID-19 Patients Requiring Oxygen Support. Microorganisms. 12(3). 440–440. 4 indexed citations
4.
Kostka, Kristin, Elena Roel, Nhung TH Trinh, et al.. (2023). The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis. Nature Communications. 14(1). 7449–7449. 9 indexed citations
5.
Mateu, Lourdes, et al.. (2023). Animal models to study the neurological manifestations of the post-COVID-19 condition. Lab Animal. 52(9). 202–210. 12 indexed citations
6.
Miranda, Cristina, Sandra González, Irma Casas, et al.. (2022). Correlation between Clinical and Immunological Variables and Humoral Response to SARS-CoV-2 Vaccination in Adult Patients with Antibody Deficiency Disorders. Pathogens. 11(11). 1364–1364. 1 indexed citations
7.
Dacosta‐Aguayo, Rosalía, Lucía A. Carrasco‐Ribelles, Rosa García‐Sierra, et al.. (2022). Neurocognitive Profile of the Post-COVID Condition in Adults in Catalonia—A Mixed Method Prospective Cohort and Nested Case–Control Study: Study Protocol. Vaccines. 10(6). 849–849. 1 indexed citations
8.
Kilpeläinen, Athina, Dan Ouchi, Ruth Peña, et al.. (2022). Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors. Frontiers in Immunology. 13. 815041–815041. 1 indexed citations
9.
Bazán, Víctor, Gemma Lladós, María Jesús Domínguez, et al.. (2022). Inappropriate sinus tachycardia in post-COVID-19 syndrome. Scientific Reports. 12(1). 298–298. 66 indexed citations
10.
Pradenas, Edwards, Benjamin Trinité, Víctor Urrea, et al.. (2021). Stable neutralizing-antibody levels 6 months after mild and severe COVID-19 episode. 29(1). 88–88.
11.
Vallejo, Núria, et al.. (2021). Long COVID-19 and microvascular disease-related angina. Revista Española de Cardiología (English Edition). 75(5). 444–446. 17 indexed citations
12.
Vallejo, Núria, et al.. (2021). COVID-19 persistente y angina microvascular. Revista Española de Cardiología. 75(5). 444–446. 7 indexed citations
13.
Mateu, Lourdes, Gema Fernández‐Rivas, & Nieves Sopena. (2020). Diagnóstico y tratamiento de la infección por Clostridioides difficile. Medicina Clínica. 155(1). 30–35. 3 indexed citations
14.
Mateu, Lourdes, Aina Teniente‐Serra, Irma Casas, et al.. (2020). Efecto de una campaña de concienciación en el diagnóstico e impacto clínico de la inmunodeficiencia primaria. Medicina Clínica. 156(6). 270–276. 3 indexed citations
15.
Ercibengoa, María, Jordi Cámara, Fé Tubau, et al.. (2019). A multicentre analysis of Nocardia pneumonia in Spain: 2010–2016. International Journal of Infectious Diseases. 90. 161–166. 31 indexed citations
16.
Vallejo, Núria, Germán Cediel, Lourdes Mateu, et al.. (2019). Short- and long-term mortality in patients with left-sided infective endocarditis not undergoing surgery despite indication. Revista Española de Cardiología (English Edition). 73(9). 734–740. 4 indexed citations
17.
Sabrià, Miquel, Irene Barrabeig, María Rosa Sala, et al.. (2019). Legionella SBT applied directly to respiratory samples as a rapid molecular epidemiological tool. Scientific Reports. 9(1). 623–623. 3 indexed citations
18.
Pedro-Botet, María Luisa, Joaquín Burgos, Manel Luján, et al.. (2014). Impact of the 2009 influenza A H1N1 pandemic on invasive pneumococcal disease in adults. Scandinavian Journal of Infectious Diseases. 46(3). 185–192. 5 indexed citations
19.
Gil, Enric Prats, et al.. (2013). Factors predicting survival in amyotrophic lateral sclerosis patients on non-invasive ventilation. European Respiratory Journal. 42(Suppl 57). P3853–P3853. 3 indexed citations
20.
Pedro-Botet, María Luisa, Nieves Sopena, Lourdes Mateu, et al.. (2006). Streptococcus pneumoniae and Legionella pneumophila pneumonia in HIV-infected patients. Scandinavian Journal of Infectious Diseases. 39(2). 122–128. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026